Biotech

All Articles

Arch shuts $3B-plus fund to encourage biopharma upstarts

.On the heels of a $3 billion fund from Bain Capital Life Sciences, Arch Venture Allies is actually ...

Orion to utilize Aitia's 'electronic twins' to locate brand new cancer medications

.Finnish biotech Orion has spied prospective in Aitia's "digital identical twin" technician to estab...

Windtree's surprise med brings up high blood pressure in newest period 2 win

.While Windtree Therapies has actually struggled to expand the financial roots needed to endure, a p...

2 cancer cells biotechs combine, generating international impact

.OncoC4 is taking AcroImmune-- as well as its own in-house medical production abilities-- under its ...

Amgen documents very first period 3 gain for $400M eczema medication

.Amgen has shared (PDF) the first period 3 records on its own $400 million dermatitis medicine, conn...

Biogen, UCB document period 3 lupus gain after stopping working earlier test

.Biogen and also UCB's rely on developing in to phase 3 on the back of a broken research looks to ha...

Aptadir really hopes brand new RNA inhibitors may turn around tricky cancers

.Italian biotech Aptadir Therapeutics has actually released along with the promise that its own pipe...

Wave surfs DMD success to regulatory authorities' doors, delivering stock up

.Wave Lifestyle Sciences has actually fulfilled its objective in a Duchenne muscular dystrophy (DMD)...

Sanofi picks brand new CSO coming from in-stealth biotech

.After a couple of years in biotech, Mike Quigley, Ph.D., is returning to the pharma layer, occupyin...

Achilles trickles cell treatment program, braces for discharges after overlooking 'office viability' targets

.Achilles Therapeutics has actually destroyed its own tactic. The British biotech is actually stoppi...